Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating)’s share price gapped down prior to trading on Friday after Evercore ISI lowered their price target on the stock from $210.00 to $175.00. The stock had previously closed at $224.75, but opened at $197.74. Intuitive Surgical shares last traded at $207.90, with a volume of 37,191 shares.
Several other research firms have also recently weighed in on ISRG. Stifel Nicolaus cut their price target on shares of Intuitive Surgical from $325.00 to $270.00 in a report on Monday. Piper Sandler lowered their price objective on Intuitive Surgical from $316.00 to $255.00 in a research report on Friday. TheStreet lowered Intuitive Surgical from a “b-” rating to a “c+” rating in a research report on Thursday, May 19th. Wolfe Research assumed coverage on Intuitive Surgical in a research report on Tuesday, April 5th. They issued a “peer perform” rating and a $315.00 price target for the company. Finally, Truist Financial lowered their price target on Intuitive Surgical from $355.00 to $270.00 and set a “buy” rating for the company in a research report on Wednesday, July 13th. Seven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $271.38.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Myriam Curet sold 6,000 shares of the stock in a transaction dated Tuesday, April 26th. The stock was sold at an average price of $252.51, for a total value of $1,515,060.00. Following the completion of the sale, the executive vice president now directly owns 361 shares in the company, valued at $91,156.11. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.90% of the stock is owned by corporate insiders.
Institutional Trading of Intuitive Surgical
Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 28,519,307 shares of the medical equipment provider’s stock worth $8,603,704,000 after buying an additional 457,262 shares in the last quarter. BlackRock Inc. raised its position in Intuitive Surgical by 0.5% in the first quarter. BlackRock Inc. now owns 26,660,811 shares of the medical equipment provider’s stock valued at $8,043,033,000 after purchasing an additional 122,151 shares during the period. State Street Corp raised its position in Intuitive Surgical by 2.3% in the first quarter. State Street Corp now owns 15,182,214 shares of the medical equipment provider’s stock valued at $4,580,170,000 after purchasing an additional 347,468 shares during the period. Capital World Investors raised its position in Intuitive Surgical by 0.3% in the first quarter. Capital World Investors now owns 9,687,380 shares of the medical equipment provider’s stock valued at $2,922,569,000 after purchasing an additional 28,839 shares during the period. Finally, Edgewood Management LLC raised its position in Intuitive Surgical by 20.3% in the first quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider’s stock valued at $2,685,761,000 after purchasing an additional 1,504,353 shares during the period. 83.69% of the stock is owned by institutional investors and hedge funds.
Intuitive Surgical Stock Down 6.1 %
The company has a market cap of $75.76 billion, a PE ratio of 49.98, a P/E/G ratio of 5.17 and a beta of 1.27. The stock has a 50-day simple moving average of $210.75 and a 200 day simple moving average of $257.01.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its earnings results on Thursday, July 21st. The medical equipment provider reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.13. Intuitive Surgical had a return on equity of 14.16% and a net margin of 27.84%. During the same period in the prior year, the company earned $1.42 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 4.24 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
